Lucid Diagnostics Inc. (LUCD) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Lucid Diagnostics Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Surgical & Medical Instruments & Apparatus
High 0.81 at 8:15 am ET, low 0.77 at 3:00 pm ET.
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, a esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
the bull case· 4
12
disclosed supplier and customer ties in SEC filings
sec filingsedgar3
of the funds on file reporting a position in LUCD
n-portas of Jun 30 '261 of 22
of the largest reporting managers who cut their stake in the latest quarter
13fJun 30 '26+54.77%
change in shares held by the ten largest reporting managers over the latest quarter
13fJun 30 '26the bear case· 1
11
managers whose positions together make up four fifths of the reported value
13fJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 16 '26 report. Not a forecast, not advice.
Of the 3 companies Lucid Diagnostics Inc. moves with most closely, none share its SEC classification.
Measured against 500 trading days of our own closes. Co-movement, not cause.
SIC 3841, Surgical & Medical Instruments & Apparatus, from each company's own filings. Largest first.
117 managers report a position worth $65.8M between them, and 11 of them hold 80% of it.
tall tick = annual report · 1 on record
LUCD (Lucid Diagnostics Inc.) has 7 disclosed suppliers and 5 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.